Minimal residual disease-guided therapy in childhood acute lymphoblastic leukemia.
作者信息
Campana Dario, Pui Ching-Hon
机构信息
Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Departments of Oncology and Pathology, St. Jude Children's Research Hospital, Memphis, TN; and.
出版信息
Blood. 2017 Apr 6;129(14):1913-1918. doi: 10.1182/blood-2016-12-725804. Epub 2017 Feb 6.
Abstract
摘要
相似文献
1
Minimal residual disease-guided therapy in childhood acute lymphoblastic leukemia.儿童急性淋巴细胞白血病的微小残留病指导治疗
Blood. 2017 Apr 6;129(14):1913-1918. doi: 10.1182/blood-2016-12-725804. Epub 2017 Feb 6.
2
Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.风险导向治疗后急性淋巴细胞白血病患儿的低复发率
J Pediatr Hematol Oncol. 2001 Dec;23(9):591-7. doi: 10.1097/00043426-200112000-00008.
3
Prognostic impact of IKZF1 deletions in association with vincristine-dexamethasone pulses during maintenance treatment of childhood acute lymphoblastic leukemia on trial ALL-BFM 95.在ALL-BFM 95试验中，IKZF1缺失与儿童急性淋巴细胞白血病维持治疗期间长春新碱-地塞米松脉冲治疗相关的预后影响。
Leukemia. 2017 Aug;31(8):1840-1842. doi: 10.1038/leu.2017.154. Epub 2017 May 22.
4
Benign intracranial hypertension in association with acute lymphoblastic leukemia.良性颅内高压与急性淋巴细胞白血病相关
Pediatr Hematol Oncol. 2003 Mar;20(2):157-60. doi: 10.1080/0880010390158667.
5
Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial.高危儿童急性淋巴细胞白血病诱导后随机分组及延迟强化治疗：国际AIEOP - BFM ALL 2000试验的长期结果
Leukemia. 2020 Jun;34(6):1694-1700. doi: 10.1038/s41375-019-0670-y. Epub 2019 Dec 5.
6
Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87.法国Fralle 83 - 87方案治疗急性淋巴细胞白血病
Leukemia. 1992;6 Suppl 2:148-52.
7
[Results and suggestion from comparing between world excellent protocols of childhood acute lymphoblastic leukemia].[儿童急性淋巴细胞白血病全球优秀治疗方案对比的结果与建议]
Zhonghua Er Ke Za Zhi. 2003 Jul;41(7):515-9.
8
Impact of early intensive reinduction therapy on event-free survival in children with low-risk acute lymphoblastic leukemia.早期强化再诱导治疗对低危急性淋巴细胞白血病患儿无事件生存期的影响。
Haematol Blood Transfus. 1990;33:483-8. doi: 10.1007/978-3-642-74643-7_87.
9
[Minimal residual disease analysis in acute lymphoblastic leukemia of childhood within the framework of COALL Study: results of an induction therapy without asparaginase].[在COALL研究框架内对儿童急性淋巴细胞白血病进行的微小残留病分析：无天冬酰胺酶诱导治疗的结果]
Klin Padiatr. 2000 Jul-Aug;212(4):169-73. doi: 10.1055/s-2000-9672.
引用本文的文献
1
False-Positive and False-Negative MRD Results in Children with Acute Lymphoblastic Leukemia: Navigating Between Scylla and Charybdis (Brief Review and Clinical Experience).急性淋巴细胞白血病患儿微小残留病检测结果的假阳性与假阴性：在锡拉岩礁和卡律布狄斯漩涡之间穿梭（简要综述与临床经验）
Children (Basel). 2025 Jun 30;12(7):860. doi: 10.3390/children12070860.
2
Cytogenetic finding of simultaneous inversion of chromosome 14 and tetrasomy 8 in a Pediatric B-Lymphoblastic Leukemia-a case report.小儿B淋巴细胞白血病中14号染色体同时倒位和8号染色体四体的细胞遗传学发现——病例报告
Mol Cytogenet. 2025 Jul 18;18(1):15. doi: 10.1186/s13039-025-00715-6.
3
Improved survival in pediatric acute lymphoblastic leukemia through therapy intensification based on minimal residual disease and protocol-driven early response risk classification.基于微小残留病和方案驱动的早期反应风险分类强化治疗可提高儿童急性淋巴细胞白血病的生存率。
Blood Res. 2025 Jul 9;60(1):40. doi: 10.1007/s44313-025-00085-3.
4
Clearing MRD positivity with blinatumomab in pediatric B-cell acute lymphoblastic leukemia: insights from droplet digital PCR and flow cytometry.使用博纳吐单抗清除儿童B细胞急性淋巴细胞白血病微小残留病阳性：来自微滴式数字PCR和流式细胞术的见解
Ann Hematol. 2025 Jan;104(1):559-564. doi: 10.1007/s00277-024-06126-8. Epub 2024 Dec 13.
5
Very early remission and increased apoptosis with the use of Pentoxifylline in children with acute lymphoblastic leukemia.在急性淋巴细胞白血病患儿中使用己酮可可碱可实现极早期缓解并增加细胞凋亡。
Front Oncol. 2024 Oct 3;14:1401262. doi: 10.3389/fonc.2024.1401262. eCollection 2024.
6
Flow Cytometry-Based Detection of Minimal/Measurable Residual Disease Predicts Survival Outcomes in Pediatrics, Adolescents, and Young Adults With T-acute Lymphoblastic Leukemia.基于流式细胞术检测微小/可测量残留病可预测儿童、青少年和年轻成人T细胞急性淋巴细胞白血病的生存结果。
Cureus. 2024 Jun 5;16(6):e61705. doi: 10.7759/cureus.61705. eCollection 2024 Jun.
7
Chimeric antigen receptor T-cell therapy for T-cell acute lymphoblastic leukemia.嵌合抗原受体 T 细胞疗法治疗 T 细胞急性淋巴细胞白血病。
Haematologica. 2024 Jun 1;109(6):1677-1688. doi: 10.3324/haematol.2023.283848.
8
Measurable residual disease (MRD)-testing in haematological and solid cancers.血液系统和实体瘤中的可测量残留病灶（MRD）检测
Leukemia. 2024 Jun;38(6):1202-1212. doi: 10.1038/s41375-024-02252-4. Epub 2024 Apr 18.
9
A pediatric-inspired regimen for adolescent and adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia: a prospective study from China.儿童诱导方案治疗费城染色体阴性的青少年及成人急性淋巴细胞白血病：来自中国的前瞻性研究。
Haematologica. 2024 Oct 1;109(10):3146-3156. doi: 10.3324/haematol.2023.284228.
10
Rituximab administration in pediatric patients with newly diagnosed acute lymphoblastic leukemia.利妥昔单抗在新诊断的儿童急性淋巴细胞白血病患者中的应用。
Leukemia. 2023 Sep;37(9):1782-1791. doi: 10.1038/s41375-023-01992-z. Epub 2023 Aug 5.
本文引用的文献
1
Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000).低强度延迟强化治疗在标准风险儿童急性淋巴细胞白血病中定义为微小残留病不可检测：一项国际随机试验（AIEOP-BFM ALL 2000）的结果。
J Clin Oncol. 2018 Jan 20;36(3):244-253. doi: 10.1200/JCO.2017.74.4946. Epub 2017 Nov 17.
2
Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia.用于B细胞急性淋巴细胞白血病高灵敏度微小残留病检测的标准化流式细胞术
Blood. 2017 Jan 19;129(3):347-357. doi: 10.1182/blood-2016-07-726307. Epub 2016 Nov 30.
3
Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapy.适应性反应治疗的不同亚型急性淋巴细胞白血病患儿微小残留病的临床影响
Leukemia. 2017 Feb;31(2):333-339. doi: 10.1038/leu.2016.234. Epub 2016 Aug 18.
4
Successful Therapy Reduction and Intensification for Childhood Acute Lymphoblastic Leukemia Based on Minimal Residual Disease Monitoring: Study ALL10 From the Dutch Childhood Oncology Group.基于微小残留病监测的儿童急性淋巴细胞白血病的成功治疗减少和强化：荷兰儿童肿瘤学组 ALL10 研究。
J Clin Oncol. 2016 Aug 1;34(22):2591-601. doi: 10.1200/JCO.2015.64.6364. Epub 2016 Jun 6.
5
CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date.用于血液系统恶性肿瘤的靶向CD19嵌合抗原受体T细胞疗法：解读迄今为止的临床结果
Blood. 2016 Jun 30;127(26):3312-20. doi: 10.1182/blood-2016-02-629063. Epub 2016 May 20.
6
EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications.儿童 B 细胞前体急性淋巴细胞白血病（BCP-ALL）中 EBF1-PDGFRB 融合：遗传学特征和临床意义。
Blood. 2016 May 5;127(18):2214-8. doi: 10.1182/blood-2015-09-670166. Epub 2016 Feb 12.
7
Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis.采用AIEOP - BFM方案在AIEOP中心治疗的儿童早期T细胞前体急性淋巴细胞白血病：一项回顾性分析
Lancet Haematol. 2016 Feb;3(2):e80-6. doi: 10.1016/S2352-3026(15)00254-9. Epub 2016 Jan 26.
8
Outcome of children with hypodiploid ALL treated with risk-directed therapy based on MRD levels.基于微小残留病（MRD）水平的风险导向治疗对低二倍体急性淋巴细胞白血病儿童的疗效
Blood. 2015 Dec 24;126(26):2896-9. doi: 10.1182/blood-2015-09-671131. Epub 2015 Nov 2.
9
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration.儿童急性淋巴细胞白血病：通过合作取得的进展
J Clin Oncol. 2015 Sep 20;33(27):2938-48. doi: 10.1200/JCO.2014.59.1636. Epub 2015 Aug 24.
10
Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232.高危B淋巴细胞白血病微小残留病的预后意义：儿童肿瘤协作组AALL0232研究报告
Blood. 2015 Aug 20;126(8):964-71. doi: 10.1182/blood-2015-03-633685. Epub 2015 Jun 29.
Zotero 插件